Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Protein Tyrosine Kinase/RTK

Items 1-10 of 128

Page
per page
  1. Selitrectinib
    C9130 Selitrectinib
    Summary: A selective TRK inhibitor, suitable for in vitro kinase signaling research, for research use only.
  2. Tirabrutinib HCl
    C9100 Tirabrutinib HCl
    Summary: A selective irreversible BTK inhibitor for research in immunology and tumor biology.
  3. DesMethyl Erlotinib HCl
    C9072 DesMethyl Erlotinib HCl
    Summary: An EGFR inhibitor compatible with CuAAC labeling, for in vitro research use.
  4. Pirtobrutinib (LOXO-305)
    C8982 Pirtobrutinib (LOXO-305)
    Summary: A BTK inhibitor
      ≥16.57 mg/mL
  5. Pralsetinib (BLU-667)
    C8979 Pralsetinib (BLU-667)
    Summary: Pralsetinib (BLU-667; CAS 2097132-94-8) is a selective RET tyrosine kinase inhibitor targeting RET signaling, widely utilized in oncology and molecular signaling research.
      ≥52.5 mg/mL
  6. Avapritinib (BLU-285)
    C8976 Avapritinib (BLU-285)
    Summary: Avapritinib (BLU-285; CAS 1703793-34-3) is a selective KIT and PDGFRA tyrosine kinase inhibitor widely utilized in oncology and signal transduction research.
      ≥15.93 mg/mL
  7. Ripretinib (DCC-2618)
    C8921 Ripretinib (DCC-2618)
    Summary: A KIT and PDGFRα inhibitor
      ≥51 mg/mL
  8. Ritlecitinib (PF-06651600)
    C8918 Ritlecitinib (PF-06651600)
    Summary: Ritlecitinib (PF-06651600; CAS 1792180-81-4) is a selective covalent JAK3/TEC family kinase inhibitor used to investigate cytokine signaling and immune-cell pathway biology.
  9. Tucatinib
    C8917 Tucatinib
    Summary: An inhibitor of HER2
      ≥25.7 mg/mL
  10. Fursultiamine
    C8914 Fursultiamine
    Summary: A derivative of vitamin B1
      ≥53.4 mg/mL

Items 1-10 of 128

Page
per page
Relate Categories
Category
  1. FGFR3item